01
What microdosing actually is
Microdosing means taking a dose small enough that you don't feel 'high.' The consumer goal is usually subtle mood or sensation shifts while staying fully functional. The term comes from psychedelic research and has been adapted by cannabis communities over the past decade. Microdosing is not a medical treatment and has not been evaluated by the FDA.
02
Why consumers experiment with low doses
Cannabinoid receptors do not need to be saturated for physiological changes to occur. At low doses, small amounts of THC bind a fraction of CB1 and CB2 receptors. Individual response varies widely. Some consumers report noticing a difference at 2 mg; others do not. This is a general consumer practice, not a clinical dosing protocol.
03
Formats consumers use for low-dose
1906 pills are formulated at 2.5 mg THC with intent-based framing, making them one of the most consistent microdose formats on the shelf. Low-dose gummies (2.5 to 5 mg) work well when you can split a piece cleanly. Capsules deliver a fixed oral dose without any prep. Smoking is harder to dose precisely because lung absorption is less controllable.
04
Who tends to prefer low doses
Consumers who find traditional doses too strong. Users who prefer to stay fully functional during daytime hours. Older users who have lost tolerance after decades away. New users still learning their response. Low-dose use does not substitute for medical treatment of any condition — see a licensed physician for health concerns.
05
How to find your low-dose baseline
Start at 1 mg THC in the morning. Note how you feel 2 hours in. If you feel nothing, bump to 2 mg next time. If you feel even mildly impaired, drop to 0.5 mg. Most consumers who stay with the practice land between 1 and 2.5 mg. Keep notes — individual response varies widely.